← FDA DRUG APPROVALS

FDA ANDA · ANDA088255

THEOPHYLLINE-SR

Sponsor: SCHERER RP

APPLICATION
ANDA088255
TYPE
ANDA
ORIGINAL APPROVAL
1986-06-12
LATEST ACTION
1986-06-12
ROUTE
ORAL
DOSAGE FORM
CAPSULE, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

THEOPHYLLINE-SRDiscontinued
THEOPHYLLINE 300MG · CAPSULE, EXTENDED RELEASE · ORAL

Approval history

1986-06-12OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →